{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T07:52:39Z","timestamp":1793951559458,"version":"4.8.0"},"reference-count":158,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100010029","name":"Taishan Scholar Foundation of Shandong Province","doi-asserted-by":"publisher","award":["tsqn201812140"],"award-info":[{"award-number":["tsqn201812140"]}],"id":[{"id":"10.13039\/501100010029","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009108","name":"Shandong University","doi-asserted-by":"publisher","award":["6010225019"],"award-info":[{"award-number":["6010225019"]}],"id":[{"id":"10.13039\/100009108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.critrevonc.2025.105022","type":"journal-article","created":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T10:11:59Z","timestamp":1763374319000},"page":"105022","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Glucocorticoid resistance in immune thrombocytopenia: A therapeutic challenge or a window for precision medicine?"],"prefix":"10.1016","volume":"217","author":[{"given":"Xin","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ningning","family":"Shan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.critrevonc.2025.105022_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2024.101222","article-title":"Immune thrombocytopenia: pathophysiology and impacts of romiplostim treatment","volume":"67","author":"Semple","year":"2024","journal-title":"Blood Rev."},{"key":"10.1016\/j.critrevonc.2025.105022_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2025.101300","article-title":"The new era of primary immune thrombocytopenia management in adults: a narrative review of current and emerging treatments","volume":"73","author":"Gonz\u00e1lez-L\u00f3pez","year":"2025","journal-title":"Blood Rev."},{"issue":"23","key":"10.1016\/j.critrevonc.2025.105022_bib3","doi-asserted-by":"crossref","first-page":"3829","DOI":"10.1182\/bloodadvances.2019000966","article-title":"American Society of Hematology 2019 Guidelines for immune thrombocytopenia","volume":"3","author":"Neunert","year":"2019","journal-title":"Blood Adv."},{"issue":"3","key":"10.1016\/j.critrevonc.2025.105022_bib4","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s12288-018-1061-7","article-title":"Clinical efficacy and safety of high-dose dexamethasone plus low-dose rituximab as first-line therapy in newly diagnosed primary immune thrombocytopenia","volume":"35","author":"Zhou","year":"2019","journal-title":"Ind. J. Hematol. Blood Transf."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.105022_bib5","doi-asserted-by":"crossref","first-page":"20","DOI":"10.31138\/mjr.28.1.20","article-title":"Lupus thrombocytopenia: pathogenesis and therapeutic implications","volume":"28","author":"Galanopoulos","year":"2017","journal-title":"Mediterr. J. Rheumatol."},{"issue":"3","key":"10.1016\/j.critrevonc.2025.105022_bib6","article-title":"The phantom platelet problem: unmasking ethylenediaminetetraacetic acid (EDTA)-induced pseudo-thrombocytopenia","volume":"17","author":"Lim","year":"2025","journal-title":"Cureus"},{"key":"10.1016\/j.critrevonc.2025.105022_bib7","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1472-6890-14-19","article-title":"A case of EDTA-dependent pseudothrombocytopenia: simple recognition of an underdiagnosed and misleading phenomenon","volume":"14","author":"Nagler","year":"2014","journal-title":"BMC Clin. Pathol."},{"issue":"17","key":"10.1016\/j.critrevonc.2025.105022_bib8","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1056\/NEJMra1413485","article-title":"Aplastic anemia","volume":"379","author":"Young","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.critrevonc.2025.105022_bib9","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1007\/s10620-019-05615-5","article-title":"Management of thrombocytopenia in patients with chronic liver disease","volume":"64","author":"Saab","year":"2019","journal-title":"Dig. Dis. Sci."},{"issue":"22","key":"10.1016\/j.critrevonc.2025.105022_bib10","doi-asserted-by":"crossref","first-page":"3780","DOI":"10.1182\/bloodadvances.2019000812","article-title":"Updated international consensus report on the investigation and management of primary immune thrombocytopenia","volume":"3","author":"Provan","year":"2019","journal-title":"Blood Adv."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.105022_bib11","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.revmed.2020.06.018","article-title":"Challenges and potential solutions in first-line treatments for immune thrombocytopenia in adults","volume":"42","author":"Godeau","year":"2021","journal-title":"La Rev. De. Med. Interne"},{"key":"10.1016\/j.critrevonc.2025.105022_bib12","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1002\/pbc.20980","article-title":"Mechanisms of action of intravenous immunoglobulin in the treatment of immune thrombocytopenia","volume":"47","author":"Crow","year":"2006","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.critrevonc.2025.105022_bib13","doi-asserted-by":"crossref","unstructured":"Imbach P., Lazarus A.H., K\u00fchne T. Intravenous Immunoglobulins Induce Potentially Synergistic Immunomodulations in Autoimmune Disorders. Vox Sanguinis, 2010, 98(3 Pt 2): 385\u2013394.","DOI":"10.1111\/j.1423-0410.2009.01264.x"},{"key":"10.1016\/j.critrevonc.2025.105022_bib14","doi-asserted-by":"crossref","unstructured":"Samuelsson A., Towers T.L., Ravetch J.V. Anti-Inflammatory Activity of IVIG Mediated through the Inhibitory Fc Receptor. Science (New York, N.Y.), 2001, 291(5503): 484\u2013486.","DOI":"10.1126\/science.291.5503.484"},{"issue":"10","key":"10.1016\/j.critrevonc.2025.105022_bib15","doi-asserted-by":"crossref","first-page":"e489","DOI":"10.1016\/S2352-3026(16)30109-0","article-title":"High-dose dexamethasone compared with prednisone for previously untreated primary immune thrombocytopenia: a systematic review and meta-analysis","volume":"3","author":"Mithoowani","year":"2016","journal-title":"Lancet Haematol."},{"issue":"7","key":"10.1016\/j.critrevonc.2025.105022_bib16","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1080\/08916934.2016.1191476","article-title":"Effects of the multidrug resistance-1 gene on drug resistance in primary immune thrombocytopenia","volume":"49","author":"Liu","year":"2016","journal-title":"Autoimmunity"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.105022_bib17","first-page":"1","article-title":"Genomic and non-genomic effects of glucocorticoids: implications for breast cancer","volume":"8","author":"Mitre-Aguilar","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"issue":"7","key":"10.1016\/j.critrevonc.2025.105022_bib18","doi-asserted-by":"crossref","first-page":"3649","DOI":"10.3390\/ijms22073649","article-title":"Glucocorticoid Receptor \u03b2 (GR\u03b2): beyond Its Dominant-Negative Function","volume":"22","author":"Ramos-Ram\u00edrez","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.critrevonc.2025.105022_bib19","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1210\/endrev\/bnae008","article-title":"The glucocorticoid receptor: isoforms, functions, and contribution to glucocorticoid sensitivity","volume":"45","author":"Lockett","year":"2024","journal-title":"Endocr. Rev."},{"issue":"1\u20135","key":"10.1016\/j.critrevonc.2025.105022_bib20","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0960-0760(02)00263-7","article-title":"Molecular mechanisms of glucocorticoid action and resistance","volume":"83","author":"Schaaf","year":"2002","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.105022_bib21","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12863-019-0718-z","article-title":"Uncovering a multitude of human glucocorticoid receptor variants: an expansive survey of a single gene","volume":"20","author":"Leventhal","year":"2019","journal-title":"BMC Genet."},{"issue":"8","key":"10.1016\/j.critrevonc.2025.105022_bib22","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.3390\/biology12081104","article-title":"Glucocorticoids and their receptor isoforms: roles in female reproduction, pregnancy, and foetal development","volume":"12","author":"Bhaumik","year":"2023","journal-title":"Biology"},{"issue":"7","key":"10.1016\/j.critrevonc.2025.105022_bib23","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/j.cell.2014.04.038","article-title":"Glucocorticoid receptor function regulated by coordinated action of the Hsp90 and Hsp70 chaperone cycles","volume":"157","author":"Kirschke","year":"2014","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.critrevonc.2025.105022_bib24","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ando.2018.03.001","article-title":"Pathophysiology of glucocorticoid signaling","volume":"79","author":"Vitellius","year":"2018","journal-title":"Ann. D. \u2019Endocrinol."},{"key":"10.1016\/j.critrevonc.2025.105022_bib25","first-page":"1867","article-title":"Cryo-EM Reveals How Hsp90 and FKBP Immunophilins Co-Regulate the Glucocorticoid Receptor","volume":"30","author":"Noddings","year":"2023"},{"issue":"7","key":"10.1016\/j.critrevonc.2025.105022_bib26","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1007\/s00277-013-1705-5","article-title":"Low expression of glucocorticoid receptor alpha isoform in adult immune thrombocytopenia correlates with glucocorticoid resistance","volume":"92","author":"Ma","year":"2013","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.critrevonc.2025.105022_bib27","article-title":"Association between NR3C1 mutations and glucocorticoid resistance in children with acute lymphoblastic leukemia","volume":"12","author":"Liu","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.105022_bib28","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1080\/16078454.2019.1710025","article-title":"Investigation on glucocorticoid receptors within platelets from adult patients with immune thrombocytopenia","volume":"25","author":"Yung","year":"2020","journal-title":"Hematology"},{"issue":"9","key":"10.1016\/j.critrevonc.2025.105022_bib29","first-page":"733","article-title":"Relationship between the expressions of glucocorticoid receptors \u03b1, \u03b2, \u03b3, p and heat shock protein 90 mRNA in patients with primary immune thrombocytopenia resistant to the glucocorticoid","volume":"33","author":"Ma","year":"2012","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"issue":"7","key":"10.1016\/j.critrevonc.2025.105022_bib30","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1080\/10245332.2015.1102371","article-title":"Relationship between expression of glucocorticoid receptor isoforms and glucocorticoid resistance in immune thrombocytopenia","volume":"21","author":"Liang","year":"2016","journal-title":"Hematology"},{"issue":"4","key":"10.1016\/j.critrevonc.2025.105022_bib31","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/pbc.21867","article-title":"Kinetics of the in vivo expression of glucocorticoid receptor splice variants during prednisone treatment in childhood acute lymphoblastic leukaemia","volume":"52","author":"Lauten","year":"2009","journal-title":"Pediatr. Blood Cancer"},{"issue":"3","key":"10.1016\/j.critrevonc.2025.105022_bib32","doi-asserted-by":"crossref","first-page":"732","DOI":"10.3324\/haematol.2021.280405","article-title":"STAT5 does not drive steroid resistance in T-cell acute lymphoblastic leukemia despite the activation of BCL2 and BCLXL following glucocorticoid treatment","volume":"108","author":"Van der Zwet","year":"2023","journal-title":"Haematologica"},{"issue":"5","key":"10.1016\/j.critrevonc.2025.105022_bib33","first-page":"363","article-title":"A study on the relationship between alpha- and beta-isoform of glucocorticoid receptors and glucocorticoid-resistant idiopathic thrombocytopenia purpura","volume":"44","author":"Zhao","year":"2005","journal-title":"Zhonghua Nei Ke Za Zhi"},{"issue":"13","key":"10.1016\/j.critrevonc.2025.105022_bib34","doi-asserted-by":"crossref","first-page":"7740","DOI":"10.1093\/nar\/gkae547","article-title":"ONECUT2 acts as a lineage plasticity driver in adenocarcinoma as well as neuroendocrine variants of prostate cancer","volume":"52","author":"Qian","year":"2024","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.105022_bib35","doi-asserted-by":"crossref","DOI":"10.1002\/iid3.1137","article-title":"Association between glucocorticoid receptor beta and steroid resistance: a systematic review","volume":"12","author":"Hasan","year":"2024","journal-title":"Immun. Inflamm. Dis."},{"issue":"5","key":"10.1016\/j.critrevonc.2025.105022_bib36","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.tibs.2024.01.012","article-title":"Glucocorticoid receptor signaling: intricacies and therapeutic opportunities","volume":"49","author":"Clarisse","year":"2024","journal-title":"Trends Biochem. Sci."},{"issue":"10","key":"10.1016\/j.critrevonc.2025.105022_bib37","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1002\/iub.245","article-title":"Emerging roles of glucocorticoid receptor phosphorylation in modulating glucocorticoid hormone action in health and disease","volume":"61","author":"Galliher-Beckley","year":"2009","journal-title":"IUBMB life"},{"key":"10.1016\/j.critrevonc.2025.105022_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.mce.2020.110873","article-title":"Protein phosphatase 1 alpha enhances glucocorticoid receptor activity by a mechanism involving phosphorylation of serine-211","volume":"518","author":"Patt","year":"2020","journal-title":"Mol. Cell. Endocrinol."},{"issue":"17","key":"10.1016\/j.critrevonc.2025.105022_bib39","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202412515","article-title":"YC-4-3, a novel glycogen synthase kinase 3\u03b2 inhibitor, alleviates the endoplasmic reticulum stress of macrophages in primary immune thrombocytopenia","volume":"12","author":"Xu","year":"2025","journal-title":"Adv. Sci."},{"issue":"Pt 3","key":"10.1016\/j.critrevonc.2025.105022_bib40","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1042\/bj20021085","article-title":"Small ubiquitin-related modifier-1 (SUMO-1) modification of the glucocorticoid receptor","volume":"367","author":"Tian","year":"2002","journal-title":"Biochem. J."},{"issue":"2","key":"10.1016\/j.critrevonc.2025.105022_bib41","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s12288-023-01702-w","article-title":"Pretreatment absolute immature platelet count is a promising predictor of response to short-term dexamethasone monotherapy or combination therapy in newly diagnosed adult primary immune thrombocytopenia","volume":"40","author":"Lv","year":"2024","journal-title":"Ind. J. Hematol. Blood Transf."},{"key":"10.1016\/j.critrevonc.2025.105022_bib42","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1301227","article-title":"Predicting the efficacy of glucocorticoids in pediatric primary immune thrombocytopenia using plasma proteomics","volume":"14","author":"Cao","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.critrevonc.2025.105022_bib43","article-title":"Unconjugated Bilirubin exerts pro-apoptotic effect on platelets via P38-MAPK activation","volume":"5","author":"NaveenKumar","year":"2015"},{"issue":"8","key":"10.1016\/j.critrevonc.2025.105022_bib44","doi-asserted-by":"crossref","first-page":"e419","DOI":"10.3324\/haematol.2019.233908","article-title":"ASK1 inhibition triggers platelet apoptosis via P38-MAPK-mediated mitochondrial dysfunction","volume":"105","author":"Manikanta","year":"2020","journal-title":"Haematologica"},{"issue":"3","key":"10.1016\/j.critrevonc.2025.105022_bib45","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1159\/000517812","article-title":"Preliminary study on apoptotic proteins in platelet from adult patients with chronic immune thrombocytopenic purpura","volume":"145","author":"Xu","year":"2022","journal-title":"Acta Haematol."},{"issue":"5","key":"10.1016\/j.critrevonc.2025.105022_bib46","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jsbmb.2004.12.046","article-title":"Gene regulation by the glucocorticoid receptor: structure:function relationship","volume":"94","author":"Kumar","year":"2005","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"18","key":"10.1016\/j.critrevonc.2025.105022_bib47","doi-asserted-by":"crossref","first-page":"10049","DOI":"10.3390\/ijms221810049","article-title":"Glucocorticoid resistance: interference between the glucocorticoid receptor and the MAPK Signalling pathways","volume":"22","author":"Sevilla","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"12","key":"10.1016\/j.critrevonc.2025.105022_bib48","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1038\/s41423-023-01089-8","article-title":"MST4 kinase regulates immune thrombocytopenia by phosphorylating STAT1-mediated M1 polarization of macrophages","volume":"20","author":"Cao","year":"2023","journal-title":"Cell. Mol. Immunol."},{"issue":"20","key":"10.1016\/j.critrevonc.2025.105022_bib49","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1002\/1873-3468.14409","article-title":"How to tame your genes: mechanisms of inflammatory gene repression by glucocorticoids","volume":"596","author":"Strickland","year":"2022","journal-title":"FEBS Lett."},{"issue":"3","key":"10.1016\/j.critrevonc.2025.105022_bib50","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1161\/ATVBAHA.109.197343","article-title":"Platelets and megakaryocytes contain functional nuclear Factor-kappaB","volume":"30","author":"Spinelli","year":"2010","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"3","key":"10.1016\/j.critrevonc.2025.105022_bib51","doi-asserted-by":"crossref","first-page":"843","DOI":"10.3324\/haematol.2022.281557","article-title":"Enhancing Regulatory T-Cell Function via Inhibition of High Mobility Group Box 1 Protein Signaling in Immune Thrombocytopenia","volume":"108","author":"Wang","year":"2023","journal-title":"Haematologica"},{"key":"10.1016\/j.critrevonc.2025.105022_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2019.154853","article-title":"Interleukin-37 reduces inflammation and impairs phagocytosis of platelets in immune thrombocytopenia (ITP)","volume":"125","author":"Zhao","year":"2020","journal-title":"Cytokine"},{"key":"10.1016\/j.critrevonc.2025.105022_bib53","first-page":"3919","article-title":"Glucocorticoids Repress NF-kappaB-Driven Genes by Disturbing the Interaction of P65 with the Basal Transcription Machinery, Irrespective of Coactivator Levels in the Cell","volume":"97","author":"De Bosscher","year":"2000"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.105022_bib54","article-title":"TNF-\u03b1 Regulates the glucocorticoid receptor alpha expression in human nasal epithelial cells Via P65-NF-\u039ab and P38-MAPK signaling pathways","volume":"21","author":"Jiang","year":"2023","journal-title":"Iran. J. Biotechnol."},{"issue":"7","key":"10.1016\/j.critrevonc.2025.105022_bib55","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000032947","article-title":"Gene mutations in the PI3K\/Akt signaling pathway were related to immune thrombocytopenia pathogenesis","volume":"102","author":"Ruan","year":"2023","journal-title":"Medicine"},{"issue":"9","key":"10.1016\/j.critrevonc.2025.105022_bib56","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.13275","article-title":"The PI3K\/AKT signalling pathway in inflammation, cell death and glial scar formation after traumatic spinal cord injury: mechanisms and therapeutic opportunities","volume":"55","author":"He","year":"2022","journal-title":"Cell Prolif."},{"key":"10.1016\/j.critrevonc.2025.105022_bib57","doi-asserted-by":"crossref","unstructured":"Nakao T., Geddis A.E., Fox N.E., et al. PI3K\/Akt\/FOXO3a Pathway Contributes to Thrombopoietin-Induced Proliferation of Primary Megakaryocytes in Vitro and in Vivo via Modulation of P27(Kip1). Cell Cycle (Georgetown, Tex.), 2008, 7(2): 257\u2013266.","DOI":"10.4161\/cc.7.2.5148"},{"key":"10.1016\/j.critrevonc.2025.105022_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106096","article-title":"Discovery of a Novel Megakaryopoiesis Enhancer, Ingenol, Promoting Thrombopoiesis through PI3K-Akt Signaling Independent of Thrombopoietin","volume":"177","author":"Wang","year":"2022","journal-title":"Pharmacol. Res."},{"issue":"7","key":"10.1016\/j.critrevonc.2025.105022_bib59","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1164\/rccm.200906-0937OC","article-title":"Targeting Phosphoinositide-3-Kinase-\u03b4 with theophylline reverses corticosteroid insensitivity in chronic obstructive pulmonary disease","volume":"182","author":"To","year":"2010","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.critrevonc.2025.105022_bib60","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.905665","article-title":"Reversal of IKZF1-induced glucocorticoid resistance by dual targeting of AKT and ERK signaling pathways","volume":"12","author":"Butler","year":"2022","journal-title":"Front. Oncol."},{"issue":"19","key":"10.1016\/j.critrevonc.2025.105022_bib61","doi-asserted-by":"crossref","first-page":"4189","DOI":"10.1016\/j.cell.2023.07.037","article-title":"Structure of the thrombopoietin-MPL receptor complex is a blueprint for biasing hematopoiesis","volume":"186","author":"Tsutsumi","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.critrevonc.2025.105022_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcmd.2024.102858","article-title":"Daucosterol Regulates JAK2-STAT3 signaling pathway to promote megakaryocyte differentiation","volume":"107","author":"Zhang","year":"2024","journal-title":"Blood Cells Mol. Dis."},{"issue":"7","key":"10.1016\/j.critrevonc.2025.105022_bib63","doi-asserted-by":"crossref","DOI":"10.1002\/cti2.70048","article-title":"SIRT7 Ameliorates Th17\/Treg imbalance by desuccinylation of STAT3 to improve immune thrombocytopenia","volume":"14","author":"Ge","year":"2025","journal-title":"Clin. Transl. Immunol."},{"issue":"20","key":"10.1016\/j.critrevonc.2025.105022_bib64","doi-asserted-by":"crossref","first-page":"4355","DOI":"10.1158\/0008-5472.CAN-20-1379","article-title":"STAT3 and GR cooperate to drive gene expression and growth of basal-like triple-negative breast cancer","volume":"80","author":"Conway","year":"2020","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.105022_bib65","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/s41419-024-06430-1","article-title":"Glucocorticoid Activates STAT3 and NF-\u03baB Synergistically with Inflammatory Cytokines to Enhance the Anti-Inflammatory Factor TSG6 Expression in Mesenchymal Stem\/Stromal Cells","volume":"15","author":"Huang","year":"2024","journal-title":"Cell Death Dis."},{"issue":"12","key":"10.1016\/j.critrevonc.2025.105022_bib66","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.1038\/leu.2017.136","article-title":"JAK\/STAT Pathway Inhibition Overcomes IL7-induced glucocorticoid resistance in a subset of human T-cell acute lymphoblastic leukemias","volume":"31","author":"Delgado-Martin","year":"2017","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2025.105022_bib67","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2021.717962","article-title":"STAT3 and IL-6 contribute to corticosteroid resistance in an OVA and ozone-induced asthma model with neutrophil infiltration","volume":"8","author":"Xue","year":"2021","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.critrevonc.2025.105022_bib68","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1210\/rp.59.1.333","article-title":"Polymorphisms in the glucocorticoid receptor gene and their associations with metabolic parameters and body composition","volume":"59","author":"Van Rossum","year":"2004","journal-title":"Recent Prog. Horm. Res."},{"issue":"6","key":"10.1016\/j.critrevonc.2025.105022_bib69","doi-asserted-by":"crossref","first-page":"3953","DOI":"10.1007\/s11033-010-0512-5","article-title":"The Bcl I single nucleotide polymorphism of the human glucocorticoid receptor gene H-GR\/NR3C1 promoter in patients with bronchial asthma: pilot study","volume":"38","author":"Pietras","year":"2011","journal-title":"Mol. Biol. Rep."},{"issue":"2","key":"10.1016\/j.critrevonc.2025.105022_bib70","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3109\/09537104.2013.779369","article-title":"Lack of association between NR3C1 polymorphism and glucocorticoid resistance in chinese patients with immune thrombocytopenia","volume":"25","author":"Xuan","year":"2014","journal-title":"Platelets"},{"key":"10.1016\/j.critrevonc.2025.105022_bib71","article-title":"Immune checkpoint-related gene polymorphisms are associated with primary immune thrombocytopenia","volume":"11","author":"Wang","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.critrevonc.2025.105022_bib72","doi-asserted-by":"crossref","DOI":"10.1016\/j.chemosphere.2022.137633","article-title":"a human-relevant mixture of endocrine disrupting chemicals induces changes in hippocampal DNA methylation correlating with hyperactive behavior in male mice","volume":"313","author":"Di Criscio","year":"2023","journal-title":"Chemosphere"},{"key":"10.1016\/j.critrevonc.2025.105022_bib73","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120940","article-title":"Lifestyle and NR3C1 exon 1F gene methylation is associated with changes in glucose levels and insulin resistance","volume":"309","author":"De Souza","year":"2022","journal-title":"Life Sci."},{"key":"10.1016\/j.critrevonc.2025.105022_bib74","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jare.2021.02.001","article-title":"Assessment of the Link of ABCB1 and NR3C1 gene polymorphisms with the prednisolone resistance in pediatric nephrotic syndrome patients of bangladesh: a genotype and haplotype approach","volume":"33","author":"Parvin","year":"2021","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.critrevonc.2025.105022_bib75","first-page":"2811","article-title":"ABCB1 gene polymorphisms and glucocorticoid-induced avascular necrosis of the femoral head susceptibility: a meta-analysis","volume":"20","author":"Li","year":"2014","journal-title":"Med. Sci. Monitor Int. Med. J. Experimental Clin. Res."},{"issue":"4","key":"10.1016\/j.critrevonc.2025.105022_bib76","first-page":"465","article-title":"Relevance of multidrug resistance 1 and P-glycoprotein to drug resistance in patients with systemic lupus erythematosus","volume":"22","author":"Tsujimura","year":"2007","journal-title":"Histol. Histopathol."},{"issue":"6","key":"10.1016\/j.critrevonc.2025.105022_bib77","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S0301-472X(03)00074-2","article-title":"Multidrug Resistance-1 (MDR-1) in Autoimmune Disorders III: Increased P-Glycoprotein Activity in Lymphocytes from Immune Thrombocytopenic Purpura Patients","volume":"31","author":"Ruiz-Soto","year":"2003","journal-title":"Exp. Hematol."},{"issue":"4","key":"10.1016\/j.critrevonc.2025.105022_bib78","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.humimm.2014.01.013","article-title":"Association of ABCB1 gene polymorphisms and haplotypes with therapeutic efficacy of glucocorticoids in Chinese patients with immune thrombocytopenia","volume":"75","author":"Xuan","year":"2014","journal-title":"Hum. Immunol."},{"issue":"6","key":"10.1016\/j.critrevonc.2025.105022_bib79","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/bcpt.13645","article-title":"In Vitro assessments predict that CYP3A4 contributes to a greater extent than CYP3A5 to prednisolone clearance","volume":"129","author":"Skauby","year":"2021","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.critrevonc.2025.105022_bib80","doi-asserted-by":"crossref","first-page":"173","DOI":"10.12688\/f1000research.2-173.v2","article-title":"Regulation of CYP3A genes by glucocorticoids in human lung cells","volume":"2","author":"Roberts","year":"2013","journal-title":"F1000Research"},{"issue":"14","key":"10.1016\/j.critrevonc.2025.105022_bib81","doi-asserted-by":"crossref","first-page":"3710","DOI":"10.1182\/bloodadvances.2023009949","article-title":"Deciphering the genetic basis of immune thrombocytopenia: current evidence for genetic predisposition in Adult ITP","volume":"7","author":"Georgi","year":"2023","journal-title":"Blood Adv."},{"issue":"4","key":"10.1016\/j.critrevonc.2025.105022_bib82","first-page":"1170","article-title":"Expression and significance of PD-1 and ICOS in patients with primary immune thrombocytopenia","volume":"30","author":"Fu","year":"2022","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"},{"issue":"5","key":"10.1016\/j.critrevonc.2025.105022_bib83","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1111\/bjh.15085","article-title":"PDCD1 and CTLA4 polymorphisms affect the susceptibility to, and clinical features of, chronic immune thrombocytopenia","volume":"180","author":"Kasamatsu","year":"2018","journal-title":"Br. J. Haematol."},{"issue":"6","key":"10.1016\/j.critrevonc.2025.105022_bib84","article-title":"Analysis of TNFSF13B Polymorphisms and BAFF expression in rheumatoid arthritis and primary Sj\u00f6gren\u2019s syndrome patients","volume":"10","author":"Santill\u00e1n-L\u00f3pez","year":"2022","journal-title":"Mol. Genet. Genom. Med."},{"key":"10.1016\/j.critrevonc.2025.105022_bib85","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.clim.2017.12.010","article-title":"Effect of glucocorticoid treatment on BAFF and APRIL expression in patients with immune thrombocytopenia (ITP)","volume":"188","author":"Kamhieh-Milz","year":"2018","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.critrevonc.2025.105022_bib86","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellimm.2020.104096","article-title":"CD4+ T cell phenotypes in the pathogenesis of immune thrombocytopenia","volume":"351","author":"Kostic","year":"2020","journal-title":"Cell. Immunol."},{"issue":"6","key":"10.1016\/j.critrevonc.2025.105022_bib87","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.3390\/jcm9061998","article-title":"Antiplatelet antibodies Do Not predict the response to intravenous immunoglobulins during immune thrombocytopenia","volume":"9","author":"Rogier","year":"2020","journal-title":"J. Clin. Med."},{"issue":"5","key":"10.1016\/j.critrevonc.2025.105022_bib88","doi-asserted-by":"crossref","first-page":"e72","DOI":"10.1111\/bjh.16334","article-title":"Increased cytotoxic potential of CD8+ T cells in immune thrombocytopenia","volume":"188","author":"Vrbensky","year":"2020","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.critrevonc.2025.105022_bib89","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/8575407","article-title":"Efficient therapeutic function and mechanisms of human polyclonal CD8+CD103+Foxp3+ regulatory T cells on collagen-induced arthritis in mice","volume":"2019","author":"Sun","year":"2019","journal-title":"J. Immunol. Res."},{"issue":"2","key":"10.1016\/j.critrevonc.2025.105022_bib90","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1182\/blood-2015-03-635417","article-title":"CD8+ T cells are predominantly protective and required for effective steroid therapy in murine models of immune thrombocytopenia","volume":"126","author":"Ma","year":"2015","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.critrevonc.2025.105022_bib91","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/bjh.17368","article-title":"The predictive value of regulatory T cells on glucocorticoid sensitivity in patients with immune thrombocytopenia: a multicentre, prospective clinical study","volume":"193","author":"Li","year":"2021","journal-title":"Br. J. Haematol."},{"issue":"2","key":"10.1016\/j.critrevonc.2025.105022_bib92","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1111\/bjh.19144","article-title":"Systemic immunosuppression depletes peripheral blood regulatory B cells in patients with immune thrombocytopenia","volume":"204","author":"Stimpson","year":"2024","journal-title":"Br. J. Haematol."},{"issue":"4","key":"10.1016\/j.critrevonc.2025.105022_bib93","doi-asserted-by":"crossref","first-page":"316","DOI":"10.4103\/ejh.ejh_53_23","article-title":"BAFF as a predictive marker for treatment response in immune thrombocytopenia patients","volume":"48","author":"Hamza","year":"2023","journal-title":"Egypt. J. Haematol."},{"issue":"4","key":"10.1016\/j.critrevonc.2025.105022_bib94","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.3390\/ijms25042163","article-title":"Current understanding of immune thrombocytopenia: a review of pathogenesis and treatment options","volume":"25","author":"Mititelu","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.critrevonc.2025.105022_bib95","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.3390\/cancers17091537","article-title":"A room for long-lived plasma cell contribution in immune cytopenias?","volume":"17","author":"Don","year":"2025","journal-title":"Cancers"},{"issue":"5","key":"10.1016\/j.critrevonc.2025.105022_bib96","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1007\/s00277-024-06105-z","article-title":"CpG can induce the proliferation and differentiation of B10 cells in the peripheral blood of children with immune thrombocytopenic purpura","volume":"104","author":"Gu","year":"2025","journal-title":"Ann. Hematol."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.105022_bib97","doi-asserted-by":"crossref","first-page":"21","DOI":"10.4238\/2015.January.15.3","article-title":"Roles of peripheral B1 cells in the individualized treatment of adult idiopathic thrombocytopenic purpura","volume":"14","author":"Luo","year":"2015","journal-title":"Genetics molecular research GMR"},{"issue":"21\u201322","key":"10.1016\/j.critrevonc.2025.105022_bib98","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1089\/scd.2023.0154","article-title":"Mesenchymal stromal cells regulate M1\/M2 macrophage polarization in mice with immune thrombocytopenia","volume":"32","author":"Liang","year":"2023","journal-title":"Stem Cells Dev."},{"issue":"9","key":"10.1016\/j.critrevonc.2025.105022_bib99","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1111\/jth.13767","article-title":"High-dose dexamethasone or all-trans-retinoic acid restores the balance of macrophages towards M2 in immune thrombocytopenia","volume":"15","author":"Feng","year":"2017","journal-title":"J. Thromb. Haemost. JTH"},{"key":"10.1016\/j.critrevonc.2025.105022_bib100","doi-asserted-by":"crossref","unstructured":"ANON, NK Cell Compartment in the Peripheral Blood and Spleen in Adult Patients with Primary Immune Thrombocytopenia. Clinical Immunology, Academic Press, 2017, 177: 18\u201328.","DOI":"10.1016\/j.clim.2015.11.005"},{"issue":"5","key":"10.1016\/j.critrevonc.2025.105022_bib101","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1007\/s10787-017-0418-0","article-title":"Regulatory effects of dexamethasone on NK and T cell immunity","volume":"26","author":"Chen","year":"2018","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.critrevonc.2025.105022_bib102","article-title":"Distinct effects of dexamethasone on human natural killer cell responses dependent on cytokines","volume":"8","author":"Morgan","year":"2017"},{"key":"10.1016\/j.critrevonc.2025.105022_bib103","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2025.107803","article-title":"The metabolism-immunity axis in immune thrombocytopenia: from energy regulation to targeted therapy","volume":"217","author":"Zhou","year":"2025","journal-title":"Pharmacol. Res."},{"issue":"7","key":"10.1016\/j.critrevonc.2025.105022_bib104","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/s41423-022-00859-0","article-title":"Glucocorticoid receptor modulates myeloid-derived suppressor cell function via mitochondrial metabolism in immune thrombocytopenia","volume":"19","author":"Hou","year":"2022","journal-title":"Cell. Mol. Immunol."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.105022_bib105","doi-asserted-by":"crossref","first-page":"6402","DOI":"10.1038\/s41467-023-42047-2","article-title":"Ebf3+ niche-derived CXCL12 Is required for the localization and maintenance of hematopoietic stem cells","volume":"14","author":"Nakatani","year":"2023","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.critrevonc.2025.105022_bib106","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s12185-020-02847-4","article-title":"Prediction of response to first-line therapy with ITP by flow cytometric analysis of bone marrow lymphocyte phenotypes","volume":"111","author":"Oka","year":"2020","journal-title":"Int. J. Hematol."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.105022_bib107","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s13287-023-03323-6","article-title":"Therapeutic potential of MSCs and MSC-derived extracellular vesicles in immune thrombocytopenia","volume":"14","author":"Wu","year":"2023","journal-title":"Stem Cell Res. Ther."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.105022_bib108","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/s41392-024-01793-5","article-title":"Efficacy and safety of human umbilical cord-derived mesenchymal stem cells in the treatment of refractory immune thrombocytopenia: a prospective, single arm, phase I Trial","volume":"9","author":"Chen","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"issue":"11","key":"10.1016\/j.critrevonc.2025.105022_bib109","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1182\/blood-2017-09-807248","article-title":"Atorvastatin enhances bone marrow endothelial cell function in corticosteroid-resistant immune thrombocytopenia patients","volume":"131","author":"Kong","year":"2018","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.critrevonc.2025.105022_bib110","first-page":"1122","article-title":"Evaluation of the effects of atorvastatin and N-Acetyl cysteine on platelet counts in patients with primary immune thrombocytopenia: an exploratory clinical trial","volume":"59","author":"Cervantes-P\u00e9rez","year":"2023","journal-title":"Med. (Kaunas. Lith. )"},{"issue":"3","key":"10.1016\/j.critrevonc.2025.105022_bib111","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1111\/bjh.17938","article-title":"Atorvastatin restores imbalance of cluster of differentiation 4 (CD4)+ T cells in immune thrombocytopenia in vivo and in vitro","volume":"201","author":"Xu","year":"2023","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.critrevonc.2025.105022_bib112","article-title":"The Treatment of Immune Thrombocytopenia (ITP)\u2014Focus on Thrombopoietin Receptor Agonists","volume":"6","author":"Kuter","year":"2021"},{"issue":"10","key":"10.1016\/j.critrevonc.2025.105022_bib113","doi-asserted-by":"crossref","first-page":"e688","DOI":"10.1016\/S2352-3026(21)00240-4","article-title":"All-trans retinoic acid plus high-dose dexamethasone as first-line treatment for patients with newly diagnosed immune thrombocytopenia: a multicentre, open-label, randomised, controlled, phase 2 trial","volume":"8","author":"Huang","year":"2021","journal-title":"Lancet Haematol."},{"issue":"3","key":"10.1016\/j.critrevonc.2025.105022_bib114","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1182\/blood.2021013393","article-title":"All-trans retinoic acid plus low-dose rituximab vs low-dose rituximab in corticosteroid-resistant or relapsed ITP","volume":"139","author":"Wu","year":"2022","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.critrevonc.2025.105022_bib115","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1007\/s00277-023-05263-w","article-title":"All-trans retinoic acid added to treatment of primary immune thrombocytopenia: a systematic review and meta-analysis","volume":"102","author":"Yang","year":"2023","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.critrevonc.2025.105022_bib116","first-page":"1","article-title":"Safety and efficacy of non-first-line drugs in the treatment of immune thrombocytopenia: a systematic review and network meta-analysis","author":"Zhou","year":"2025","journal-title":"Expert Rev. Hematol."},{"issue":"9610","key":"10.1016\/j.critrevonc.2025.105022_bib117","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0140-6736(08)60203-2","article-title":"Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial","volume":"371","author":"Kuter","year":"2008","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.critrevonc.2025.105022_bib118","doi-asserted-by":"crossref","first-page":"e315","DOI":"10.1016\/S2352-3026(15)00114-3","article-title":"Eltrombopag for the treatment of children with persistent and chronic immune thrombocytopenia (PETIT): a randomised, multicentre, placebo-controlled study","volume":"2","author":"Bussel","year":"2015","journal-title":"Lancet Haematol."},{"issue":"3","key":"10.1016\/j.critrevonc.2025.105022_bib119","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/bjh.15573","article-title":"Phase 3 randomised study of avatrombopag, a novel thrombopoietin receptor agonist for the treatment of chronic immune thrombocytopenia","volume":"183","author":"Jurczak","year":"2018","journal-title":"Br. J. Haematol."},{"issue":"3","key":"10.1016\/j.critrevonc.2025.105022_bib120","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/ejh.12821","article-title":"Long-term results of splenectomy in adult chronic immune thrombocytopenia","volume":"98","author":"Guan","year":"2017","journal-title":"Eur. J. Haematol."},{"issue":"19","key":"10.1016\/j.critrevonc.2025.105022_bib121","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1182\/blood-2018-11-852491","article-title":"Fostamatinib for the treatment of chronic immune thrombocytopenia","volume":"133","author":"Connell","year":"2019","journal-title":"Blood"},{"issue":"23","key":"10.1016\/j.critrevonc.2025.105022_bib122","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1056\/NEJMoa2400409","article-title":"A novel anti-CD38 monoclonal antibody for treating immune thrombocytopenia","volume":"390","author":"Chen","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.critrevonc.2025.105022_bib123","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcmd.2023.102724","article-title":"Daratumumab as a novel treatment option in refractory ITP","volume":"99","author":"Vernava","year":"2023","journal-title":"Blood Cells Mol. Dis."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.105022_bib124","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/bjh.19078","article-title":"Novel therapeutics and future directions for refractory immune thrombocytopenia","volume":"203","author":"Al-Samkari","year":"2023","journal-title":"Br. J. Haematol."},{"issue":"24","key":"10.1016\/j.critrevonc.2025.105022_bib125","doi-asserted-by":"crossref","first-page":"2914","DOI":"10.1182\/blood.2024027336","article-title":"Safety and efficacy of rilzabrutinib vs placebo in adults with immune thrombocytopenia: the phase 3 LUNA3 Study","volume":"145","author":"Kuter","year":"2025","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.critrevonc.2025.105022_bib126","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1182\/bloodadvances.2021006864","article-title":"Safety and efficacy of classical complement pathway inhibition with sutimlimab in chronic immune thrombocytopenia","volume":"7","author":"Broome","year":"2023","journal-title":"Blood Adv."},{"key":"10.1016\/j.critrevonc.2025.105022_bib127","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1097\/01.HS9.0000849456.78394.f9","article-title":"P1650: metabolic abnormality and glucocorticoid receptor modulation of myeloid-derived suppressor cells in immune thrombocytopenia patients and an active murine model","volume":"6","author":"Wang","year":"2022","journal-title":"HemaSphere"},{"key":"10.1016\/j.critrevonc.2025.105022_bib128","doi-asserted-by":"crossref","unstructured":"ANON, Autoimmune Effector Mechanisms Associated with a Defective Immunosuppressive Axis in Immune Thrombocytopenia (ITP). Autoimmunity Reviews, Elsevier, 2024, 23(12): 103677.","DOI":"10.1016\/j.autrev.2024.103677"},{"issue":"7","key":"10.1016\/j.critrevonc.2025.105022_bib129","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1080\/10245332.2015.1102371","article-title":"Relationship between expression of glucocorticoid receptor isoforms and glucocorticoid resistance in immune thrombocytopenia","volume":"21","author":"Liang","year":"2016","journal-title":"Hematology"},{"issue":"7","key":"10.1016\/j.critrevonc.2025.105022_bib130","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1007\/s00277-013-1705-5","article-title":"Low expression of glucocorticoid receptor alpha isoform in adult immune thrombocytopenia correlates with glucocorticoid resistance","volume":"92","author":"Ma","year":"2013","journal-title":"Ann. Hematol."},{"issue":"10","key":"10.1016\/j.critrevonc.2025.105022_bib131","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202570066","article-title":"Exosome-mediated lectin pathway and resistin-MIF-AA metabolism axis drive immune dysfunction in immune thrombocytopenia","volume":"12","author":"Li","year":"2025","journal-title":"Adv. Sci."},{"key":"10.1016\/j.critrevonc.2025.105022_bib132","article-title":"SIRT1: potential target in glucocorticoid-resistant diseases","volume":"16","author":"Xie","year":"2025","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.105022_bib133","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1182\/hematology.2024000594","article-title":"Insights on treatment of Adult ITP: algorithm for management and role of multimodal therapy","volume":"2024","author":"Ghanima","year":"2024","journal-title":"Hematol. Am. Soc. Hematol. Educ. Program"},{"issue":"6","key":"10.1016\/j.critrevonc.2025.105022_bib134","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1182\/blood.2024024250","article-title":"Fostamatinib effectiveness and safety for immune thrombocytopenia in clinical practice","volume":"144","author":"Gonz\u00e1lez-L\u00f3pez","year":"2024","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.critrevonc.2025.105022_bib135","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1093\/rheumatology\/keae041","article-title":"A path to glucocorticoid stewardship: a critical review of clinical recommendations for the treatment of systemic lupus erythematosus","volume":"63","author":"Bertsias","year":"2024","journal-title":"Rheumatology"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.105022_bib136","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1136\/ard-2023-224762","article-title":"EULAR Recommendations for the management of systemic lupus erythematosus: 2023 update","volume":"83","author":"Fanouriakis","year":"2024","journal-title":"Ann. Rheum. Dis."},{"issue":"14","key":"10.1016\/j.critrevonc.2025.105022_bib137","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1182\/blood-2009-07-229815","article-title":"Dexamethasone plus Rituximab yields higher sustained response rates than dexamethasone monotherapy in adults with primary immune thrombocytopenia","volume":"115","author":"Zaja","year":"2010","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.105022_bib138","doi-asserted-by":"crossref","DOI":"10.1080\/09537104.2023.2258988","article-title":"Anti-GPIb\/IX autoantibodies are associated with poor response to dexamethasone combined with rituximab therapy in primary immune thrombocytopenia patients","volume":"34","author":"Ding","year":"2023","journal-title":"Platelets"},{"issue":"25","key":"10.1016\/j.critrevonc.2025.105022_bib139","doi-asserted-by":"crossref","first-page":"3906","DOI":"10.1182\/blood-2014-01-549360","article-title":"Eltrombopag and high-dose dexamethasone as frontline treatment of newly diagnosed immune thrombocytopenia in adults","volume":"123","author":"G\u00f3mez-Almaguer","year":"2014","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.critrevonc.2025.105022_bib140","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1182\/blood-2012-09-455691","article-title":"Rituximab and dexamethasone vs dexamethasone monotherapy in newly diagnosed patients with primary immune thrombocytopenia","volume":"121","author":"Gudbrandsdottir","year":"2013","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.critrevonc.2025.105022_bib141","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.3390\/ph16091215","article-title":"Therapeutic outcomes of high dose-dexamethasone versus prednisolone + azathioprine, rituximab, eltrombopag, and romiplostim strategies in persistent, chronic, refractory, and relapsed immune thrombocytopenia patients","volume":"16","author":"Hamed","year":"2023","journal-title":"Pharmaceuticals"},{"issue":"3","key":"10.1016\/j.critrevonc.2025.105022_bib142","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1007\/s10067-023-06777-4","article-title":"Intrathecal injection of methotrexate and dexamethasone for vasculitis granuloma of the fourth ventricle: a case report and literature review","volume":"43","author":"Li","year":"2024","journal-title":"Clin. Rheumatol."},{"issue":"12","key":"10.1016\/j.critrevonc.2025.105022_bib143","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1002\/ajh.25989","article-title":"High-dose dexamethasone plus recombinant human thrombopoietin vs high-dose dexamethasone alone as frontline treatment for newly diagnosed adult primary immune thrombocytopenia: a prospective, multicenter, randomized trial","volume":"95","author":"Yu","year":"2020","journal-title":"Am. J. Hematol."},{"issue":"2","key":"10.1016\/j.critrevonc.2025.105022_bib144","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/bjh.16327","article-title":"Safety and efficacy of eltrombopag plus pulsed dexamethasone as first-line therapy for immune thrombocytopenia","volume":"189","author":"Zhang","year":"2020","journal-title":"Br. J. Haematol."},{"issue":"4","key":"10.1016\/j.critrevonc.2025.105022_bib145","doi-asserted-by":"crossref","first-page":"e289","DOI":"10.1016\/S2352-3026(21)00030-2","article-title":"Dexamethasone plus oseltamivir versus dexamethasone in treatment-naive primary immune thrombocytopenia: a multicentre, randomised, open-label, phase 2 trial","volume":"8","author":"Sun","year":"2021","journal-title":"Lancet Haematol."},{"issue":"10","key":"10.1016\/j.critrevonc.2025.105022_bib146","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1056\/NEJMoa2100596","article-title":"Mycophenolate mofetil for first-line treatment of immune thrombocytopenia","volume":"385","author":"Bradbury","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.105022_bib147","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1684\/ejd.2015.2691","article-title":"Glucocorticoid receptors GR\u03b1 and GR\u03b2 are expressed in inflammatory dermatoses","volume":"26","author":"Kubin","year":"2016","journal-title":"Eur. J. Dermatol. EJD"},{"issue":"5","key":"10.1016\/j.critrevonc.2025.105022_bib148","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1042\/BST20210419","article-title":"Structural insights into glucocorticoid receptor function","volume":"49","author":"Frank","year":"2021","journal-title":"Biochem. Soc. Trans."},{"issue":"3","key":"10.1016\/j.critrevonc.2025.105022_bib149","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/nrm.2016.152","article-title":"Glucocorticoid receptor control of transcription: precision and plasticity via allostery","volume":"18","author":"Weikum","year":"2017","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"15","key":"10.1016\/j.critrevonc.2025.105022_bib150","doi-asserted-by":"crossref","first-page":"3403","DOI":"10.3390\/jcm10153403","article-title":"Potential diagnostic approaches for prediction of therapeutic responses in immune thrombocytopenia","volume":"10","author":"Jolink","year":"2021","journal-title":"J. Clin. Med."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.105022_bib151","doi-asserted-by":"crossref","DOI":"10.1002\/iid3.1137","article-title":"Association between glucocorticoid receptor beta and steroid resistance: a systematic review","volume":"12","author":"Hasan","year":"2024","journal-title":"Immun. Inflamm. Dis."},{"issue":"7","key":"10.1016\/j.critrevonc.2025.105022_bib152","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1038\/s41423-022-00880-3","article-title":"Impaired glucocorticoid receptor expression and mitochondrial metabolism in MDSCs contribute to glucocorticoid resistance in immune thrombocytopenia","volume":"19","author":"Kapur","year":"2022","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.critrevonc.2025.105022_bib153","doi-asserted-by":"crossref","DOI":"10.1155\/2023\/9573863","article-title":"Proteomic-based discovery of predictive biomarkers for drug therapy response and personalized medicine in chronic immune thrombocytopenia","volume":"2023","author":"Gilanchi","year":"2023","journal-title":"BioMed. Res. Int."},{"issue":"4","key":"10.1016\/j.critrevonc.2025.105022_bib154","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1111\/bjh.70072","article-title":"Urine proteomics uncovers biomarker candidates for early identifying rituximab beneficiaries in paediatric steroid-resistant immune thrombocytopenia","volume":"207","author":"Yu","year":"2025","journal-title":"Br. J. Haematol."},{"issue":"9","key":"10.1016\/j.critrevonc.2025.105022_bib155","first-page":"4229","article-title":"Efgartigimod as a novel FcRn inhibitor for autoimmune disease","volume":"45","author":"Yang","year":"2024","journal-title":"Neurol. Sci. Off. J. Ital. Neurol. Soc. Ital. Soc. Clin. Neurophysiol."},{"key":"10.1016\/j.critrevonc.2025.105022_bib156","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.111827","article-title":"The role of BAFF and BAFF-R inhibitors in the treatment of immune thrombocytopenia; a focused review","volume":"131","author":"Nilforoushzadeh","year":"2024","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.105022_bib157","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1124\/jpet.123.001752","article-title":"Preclinical pharmacology characterization of sovleplenib (HMPL-523), an orally available syk inhibitor","volume":"388","author":"Cai","year":"2024","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.105022_bib158","doi-asserted-by":"crossref","DOI":"10.1080\/09537104.2022.2131751","article-title":"Recent advances in understanding spleen tyrosine kinase (SYK) in human biology and disease, with a focus on fostamatinib","volume":"34","author":"Cooper","year":"2023","journal-title":"Platelets"}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104084282500410X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104084282500410X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T05:45:32Z","timestamp":1773812732000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S104084282500410X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":158,"alternative-id":["S104084282500410X"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2025.105022","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glucocorticoid resistance in immune thrombocytopenia: A therapeutic challenge or a window for precision medicine?","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2025.105022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"105022"}}